Open AccessBook
Myasthenia Gravis
Huub Oosterhuis
- 01 Jan 1997
2.4K
About: The article was published on 01 Jan 1997. and is currently open access. The article focuses on the topics: Myasthenia gravis & Ocular myasthenia.
read more
Chat with Paper
AI Agents for this Paper
Find similar papers on Google Scholar, PubMed and Arxiv
Write a critical review of this paper
Analyze citations of this paper to find unaddressed research gaps
Citations
Predictors of outcome in thymectomy for myasthenia gravis.
TL;DR: Sex, age, and thymic pathology are potential predictors of outcome in thymectomy for MG, and may shape treatment decisions and target higher-risk patients.
129
Soluble complement receptor 1 (sCR1) protects against experimental autoimmune myasthenia gravis.
TL;DR: The effects of a soluble recombinant form of human complement receptor 1 (sCR1) on the development of clinical disease and receptor loss in EAMG induced passively by administration of anti-AChR antibodies are described and suggest that sCR1 could provide a useful additional therapeutic agent in myasthenia.
127
Myasthenia gravis and infectious disease.
TL;DR: This is a review article, where Web of Science has been searched for relevant key words and key word combinations to find papers with relevance for the risk of infections as well as their prophylactic and curative treatment.
127
Efficacy of prednisone for the treatment of ocular myasthenia (EPITOME): A randomized, controlled trial
Michael Benatar,Michael P. McDermott,Donald B. Sanders,Gil I. Wolfe,Richard J. Barohn,Richard J Nowak,Michael K. Hehir,Vern C. Juel,Hans D. Katzberg,Rabi Tawil +9 more
TL;DR: A strategy of low‐dose prednisone with gradual escalation appears to be safe, well‐tolerated, and effective in treating OMG.
Teratogen update: maternal myasthenia gravis as a cause of congenital arthrogryposis.
TL;DR: Although rare, anti-AChR-associated AMC is potentially treatable and can be diagnosed by a routine antibody test, and the mouse model is used to investigate the role of maternal antibodies in causing congenital conditions.
125